Abiomed is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.


Updates from The Motley Fool

Latest updates on Abiomed from Fool.com.  The Fool has written over 100 articles on Abiomed.
3 Terrible Stocks for Retirees

Healthcare's usually a great sector for retirees, but these stocks just don't fit the bill.



Stock Performance

View Interactive ABMD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Abiomed.
Current Price: $362.42
Prev Close: $386.63
Open: $388.41
Bid: $360.50
Ask: $367.60
Day's Range: $360.63 - $391.70
52wk Range: $164.80 - $459.75
Volume: 850,471
Avg Vol 656,081
Market Cap: $16B
P/E (ttm): 108.00
EPS (ttm): $3.58
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Abiomed.
CAPS Rating 5 out of 5
 
286 Outperform
37 Underperform
CAPS All Stars
 
75 Outperform
12 Underperform

How do you think Abiomed will perform against the market?



You pick for Abiomed is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael R. Minogue, CEO

90% Approve

Based on 62 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Abiomed.

Abiomed is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT